Business Monitor International


Filter results

Pharmaceutical Reports

Showing 1-20 of 179
Sort By
Algeria Pharmaceuticals & Healthcare Report

Algeria Pharmaceuticals & Healthcare Report

Pub date:28 May 2014

BMI View:   The  Algerian government 's   aspirations to rebalance the pharmaceutical trade deficit and promot e local generic produc tion , whilst enhancing the country's competitiveness by stimulating the innovative biopharmaceutical industry as a st rategic ...
$1,295.00
Read More...
Angola Pharmaceuticals & Healthcare Report

Angola Pharmaceuticals & Healthcare Report

Pub date:28 May 2014

BMI View: Both government and foreign investment will see the Angolan healthcare sector continue to grow in the coming years mainly due the country ' s rich oil reserves attracting external revenues. Angola ' s ...
$1,295.00
Read More...
Argentina Pharmaceuticals & Healthcare Report

Argentina Pharmaceuticals & Healthcare Report

Pub date:27 May 2014

BMI View: The Argentine economy is still reeling from the January 2014 currency devaluation. Soaring inflation and stringent drug pricing controls will continue to discourage investment and erode the growth of the country's pharmaceutical market. More ...
$1,295.00
Read More...
Australia Pharmaceuticals & Healthcare Report

Australia Pharmaceuticals & Healthcare Report

Pub date:25 Apr 2014

BMI View:   Over 300 drug formulations listed on the Pharmaceutical Benefits Scheme (PBS) will be subject to price reduction from October 1 2014, following the first simplified price disclosure (SPD) cycle in Australia. As a result, the prices ...
$1,295.00
Read More...
Austria Pharmaceuticals & Healthcare Report

Austria Pharmaceuticals & Healthcare Report

Pub date:19 May 2014

BMI View : Austria's economy is set to grow at a faster clip in the second half of 2014 and domestic consumer demand is poised to strengthen in this period. We have revised the healthcare and pharmaceutical ...
$1,295.00
Read More...
Bahrain Pharmaceuticals & Healthcare Report

Bahrain Pharmaceuticals & Healthcare Report

Pub date:11 Apr 2014

BMI View: Bahrain ' s National Health Regulatory Authority has begun implementing its multi-phased plan to significantly reduce medicine prices in the country. The price cuts are the result of a Gulf Cooperation Council decision ...
$1,295.00
Read More...
Bangladesh Pharmaceuticals & Healthcare Report

Bangladesh Pharmaceuticals & Healthcare Report

Pub date:27 May 2014

BMI View: While economic growth is boosting demand for pharmaceuticals in Bangladesh, income inequality continues to drive the purchase of counterfeit medicines. In November 2013, the government vowed to continue fighting the growing industry of substandard, ...
$1,295.00
Read More...
Belarus Pharmaceuticals & Healthcare Report

Belarus Pharmaceuticals & Healthcare Report

Pub date:02 Jun 2014

BMI View: The Belarusian economy is set to suffer a prolonged period of economic instability as a result of a decline in global potash prices and an escalating trade war with Russia. If Russo-Belarusian relations ...
$1,295.00
Read More...
Belgium Pharmaceuticals & Healthcare Report

Belgium Pharmaceuticals & Healthcare Report

Pub date:30 May 2014

BMI View: Belgium continues to attract the attention of multinational firms as a European hub for clinical trials, new drug development and niche research. However, a highly developed pharmaceutical manufacturing industry is increasingly threatened by ...
$1,295.00
Read More...
Botswana Pharmaceuticals & Healthcare Report

Botswana Pharmaceuticals & Healthcare Report

Pub date:02 Jun 2014

BMI View: We remain relatively optimistic over the growth potential of Botswana's pharmaceutical and healthcare sector, given the government's aim to improve healthcare. However, implementation of these healthcare aims remain a risk, as issues such ...
$1,295.00
Read More...
Brazil Pharmaceuticals & Healthcare Report

Brazil Pharmaceuticals & Healthcare Report

Pub date:29 May 2014

BMI View: The Brazilian pharmaceutical market will continue to be the most attractive to multinational pharmaceutical companies in Latin America. S trong government support, an improving regulatory regime and significant private healthcare growth mean that ...
$1,295.00
Read More...
Bulgaria Pharmaceuticals & Healthcare Report

Bulgaria Pharmaceuticals & Healthcare Report

Pub date:20 May 2014

BMI View: T he Ministry of Health 's plan to increase MAH fees, coupled with price cuts for generic drugs and freezes on OTC medicine prices indicate that the Bulgarian pharmaceutical market will not see ...
$1,295.00
Read More...
Cambodia Pharmaceuticals & Healthcare Report

Cambodia Pharmaceuticals & Healthcare Report

Pub date:11 Apr 2014

SWOT Analysis Strengths One of the more prominent local companies in the country. Affiliated with CNN Generics Distribution. Weaknesses Strict price controls, with the government refocusing its efforts to reduce prices as a means to ...
$1,295.00
Read More...
Cameroon Pharmaceuticals & Healthcare Report

Cameroon Pharmaceuticals & Healthcare Report

Pub date:28 May 2014

BMI View:   A combination of the adoption of different mobile health innovations, health-targeted foreign aid inflows and sustained infrastructure investment will continue to create opportunities for health sector improvement in Cameroon over the medium term. ...
$1,295.00
Read More...
Canada Pharmaceuticals & Healthcare Report

Canada Pharmaceuticals & Healthcare Report

Pub date:19 May 2014

BMI View: The Canadian pharmaceutical and healthcare market will become increasingly attractive to pharmaceutical companies over the next few years as e conomic growth in the country gradually accelerate s. The hospitable business environment, improving ...
$1,295.00
Read More...
Central America Pharmaceuticals & Healthcare Report

Central America Pharmaceuticals & Healthcare Report

Pub date:28 Apr 2014

BMI View: Panama and Costa Rica will continue to outperform in compar ison with other Central American countries, namely El Salvador, Guatemala, Honduras, Nicaragua and Belize . I mproving healthcare investment present revenue-generating opportunities for multinational ...
$1,295.00
Read More...
Chile Pharmaceuticals & Healthcare Report

Chile Pharmaceuticals & Healthcare Report

Pub date:23 Jun 2014

BMI View: Private healthcare insurance companies in Chile will face increasing risks due to the Isapres reform in terms of lower profits and challenges resulting from the separation of insurance and clinic management business units. ...
$1,295.00
Read More...
China Pharmaceuticals and Healthcare Report

China Pharmaceuticals and Healthcare Report

Pub date:20 Mar 2014

BMI View: In line with our optimism towards the Chinese healthcare sector, many multinational pharmaceutical firms continue to record healthy double-digit revenue growth in Q114, despite the economic slowdown. Given the attractiveness of the Chinese ...
$1,295.00
Read More...
Colombia Pharmaceuticals & Healthcare Report

Colombia Pharmaceuticals & Healthcare Report

Pub date:27 May 2014

BMI View:   President Juan Manuel Santos' re-election in June has given him a strong mandate to continue the process of healthcare reform in Colombia. Although the Santos administration has been successful in limit ing medicine ...
$1,295.00
Read More...
Cote d'Ivoire Pharmaceuticals & Healthcare Report

Cote d'Ivoire Pharmaceuticals & Healthcare Report

Pub date:19 May 2014

BMI View:  Cote d'Ivoire remains one of the least attractive pharmaceutical markets to multinationals looking to launch innovative products in Africa. This is due to poor patent respect, lack of policy enforcement and approvals expediency ...
$1,295.00
Read More...
Showing 1-20 of 179
Sort By